Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients

OBJECTIVE: To estimate the cost-effectiveness of fluticasone propionate–salmeterol combination (FSC) compared to salmeterol for maintenance therapy in severe chronic obstructive pulmonary disease (COPD). STUDY DESIGN: Pooled economic analysis. METHODS: We performed an economic analysis of pooled dat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dalal, Anand A, St Charles, Meaghan, Petersen, Hans V, Roberts, Melissa H, Blanchette, Christopher M, Manavi-Zieverink, Kathy
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2010
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921685/
https://ncbi.nlm.nih.gov/pubmed/20714371
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars